Closed blood sampling system helps in reducing the blood waste and further prevents the transmission of infectious diseases, owing to its needle-free and closed sampling system. This sampling system was developed to make the blood sampling process efficient. This process works by having blood storage tank, which stores the blood in the reservoir and does not allow repetitive blood isolation from the site of sampling, including antecubital area, wrist, hand or foot. Blood Sampling process monitors the circulation of blood in patients admitted to ICU.
Closed blood sampling process is the most preferred technique than conventional blood sampling process owing to minimal blood waste in the closed blood sampling. Moreover, according to National Center for Biotechnology Information (NCBI), there are minimal fluctuations seen in the hematocrit and hemoglobin counts when a blood sample is taken by closed blood sampling technique. Furthermore, it leads to minimal blood loss in patients, thereby, it is recommended sampling system for critically ill patients facing trauma and other serious diseases.
Global closed blood sampling system market is driven by factors such as the rising number of surgeries. According to the World Health Organization, there was a hike of 38% in the number of surgeries performed, which means approximately 359.5 million surgical operations were done in 2012, as compared to the previous year and is predicted to rise in the pcoming years. Moreover, rising demand for blood transfusion and number of emergency cases is attributed to propel the growth of the market. Furthermore, According to National Center for Biotechnology Information (NCBI), approximately 30-37% of patients are receiving blood transfusion while operated in ICU, which is anticipated to increase the demand of closed blood sampling system process. Furthermore, closed blood sampling technique helps in reducing iatrogenic anemia. Hence, it minimizes the risk of negative transfusion effects and reduces the possible necessity of transfusion of blood. Moreover, rising prevalence of diseases and trauma, including cancer, anemia, diabetes, HIV/AIDS, coronary heart diseases, and rare diseases is attributed to drive the growth of the market. According to the estimation of Centers for Disease Control and Prevention (CDC), around 26,203 incidences of Lyme diseases were found between 2006 to 2016, in the U.S. Moreover, approximately 10,265 deaths were noted because of alcohol-impaired driving in 2015, in the US.
Geographically, closed blood sampling system market can be segmented as North America, Europe, Asia Pacific and LAMEA. North America holds the dominant position in closed blood sampling system market, followed by the Asia Pacific. Rising number of surgical operations and growing need for blood transfusions, owing to rising prevalence of diseases, is anticipated to propel the growth of the market. For instance, according to the American National Red Cross, a humanitarian organization, almost 21 million blood medical are transfused in the United States every year.
In 2017, according to the estimation of American Cancer Society, approximately 1.7 million individuals were diagnosed with cancer. Several of them needed chemotherapy treatment.
Furthermore, the establishment of new clinics and blood banks and increasing use of blood products, owing to the rising number of blood transfusion processes is driving the market in Asia Pacific region during the forecast period.
According to the data published by National AIDS Control Organization (NACO) in 2014, the total demand for blood components and blood is approximately 1% of total population of India that is 12 million units of blood.
Major players in the market are Edwards Lifesciences Corporation, Smiths Medical, ICU Medical, Inc., CardioMed Supplies Inc., Utah Medical Products, Inc., Argon Medical Devices, Inc., Fannin Ltd., Ashcon International Inc., Velano Vascular, Inc., and Merit Medical Systems, Inc.
In January 2016, a global leader medical device company, Velano Vascular, Inc. received the approval from U.S. Food and Drug Administration (FDA) for making the latest version of the needle-free device that was being developed for reducing discomforts and anxiety in patients.
• By Product Type
o Blood Sampling Accessories
o Blood Sampling System
• By Application
• By End Users
o Hospitals and Nursing Homes
o Surgical Clinics
o Blood Banks
o Diagnostic Centers
• Regions Covered:
o North America (U.S and Canada)
o Europe (Germany, France, Italy and Rest of Europe)
o Asia-Pacific (China, Japan, India, South Korea and Rest of Asia-Pacific)
o LAMEA (Brazil, Turkey, Saudi Arabia, South Africa and Rest of LAMEA)